6
CURRICULUM VITAE Part A. PERSONAL INFORMATION First and Family name Narcisa Martínez Quiles Social Security, Passport, ID number 29039413G Age 53 Researcher codes WoS Researcher ID (*) G-8514-2013 SCOPUS Author ID(*) 6602244874 Open Researcher and Contributor ID (ORCID) ** 0000-0002-0366-6591 (*) At least one of these is mandatory (**) Mandatory A.1. Current position Name of University/Institution Complutense University of Madrid Department Immunology-Ophtalmology-ENT Address and Country Facultad de Medicina, Spain Phone number 913947431 E-mail [email protected] Current position Professor (PTU) From 2016-11-15 Key words Cytoskeleton, Actin, cell motility, EPEC, Wiskott-Aldrich Syndrome, Autoinflammatory diseases (Innate Signaling-Cytoskeleton) A.2. Education PhD University Year Doctor in Biology (Medical Immunology Program) Complutense Univ. (Hospital “12 de Octubre”) 1997 Licenciado en Biologia (equivalent to Master’s level) Autónoma University of Madrid 1982 A.3. JCR articles, h Index, thesis supervised… 4 Periods of 6 years of research officially recognized by CNEAI (sexenios, last 2015). Supervisor of 3 Ph.D. Thesis: 3 (1 co-directed), 2 with European Mention. Supervision of Students thesis: 3 graduation´s thesis, 5 master’s Thesis. Publications: 46% Q1; 26% D1. WOS Total citations: 948. Average citation 2012-16: 47. H index: 12. Outstanding publications: Predoctoral: J. Immunology (1st author); Post-doctoral: Nature Cell Biology (1st author), PI: Plos Pathogens (corresponding and last author); Cell Host and Microbe (collaboration). Part B. CV SUMMARY (max. 3500 characters, including spaces) Narcisa Martínez Quiles (NMQ) is a Professor (Titular) at the Complutense University. Graduated in Biology, specialty of Biochemistry and Molecular Biology by Autónoma University (1989). She ranked 4 / 628 in a national examination that allow her to join the National Biologist Residency Program (BIR) at the “12 de Octubre” Hospital, in the Immunology Division (1992-5). After its successful completion, she obtained the national certification by the Health Ministry as Immunologist Specialist that grants access to Hospitals. During this period, she participated in research and published several studies, including a Journal of Immunology as first author. She joined the Medical Immunology doctorate program at the UCM and obtained the doctoral degree in 1997. Although she was offered to continue in the division, at this point she decided to join the laboratory of Dr. Raif S. Geha, (Immunology Division, Children´s Hospital, Harvard Medical School) where she contributed to the study of the “Wiskott-Aldrich Syndrome”. She stayed there for 5 years as a postodoctoral fellow and two more years as an instructor/Research Associate (Dept. of Medicine, Harvard Medical School). This period shaped her scientifically and allow her to publish the research in top journals, such as Nature Cell Biology (first author). She received several awards, including the Paul A. Dobuler Prize for Excellence in Immunodeficiency Research. As a postdoctoral fellow, she was in charge of setting-up new cytoskeletal study techniques including cell microinjection. In 2004, she decided to return to Spain and applied to the very competitive public national program “Ramon y Cajal” where she ranked fifth in the Biomedicine area. In September of 2004 she joined the Dpt. of Microbiology, at the Pharmacy School, with the aim of refining its knowledge in host-pathogen interaction mechanisms in relation to the cytoskeleton. After the completion of this 5 year period, she obtained an I3 positive evaluation from the Ministry of Science that facilitated obtaining a contract as a Professor ( Profesor Contratado Doctor) in September of 2009. In October of 2012 the researcher moves to the Dept. of Immunology, at the UCM Medical School. Although she obtained the certification as a civil servant professor (PTU) in 2011, due to the economic CV date 2020-01-30

CURRICULUM VITAE€¦ · crisis, is not until 2016 that she was able to apply for the position. Therefore, she is PTU from November of 2016 (equivalent to tenured professor). NMQ

  • Upload
    others

  • View
    4

  • Download
    0

Embed Size (px)

Citation preview

Page 1: CURRICULUM VITAE€¦ · crisis, is not until 2016 that she was able to apply for the position. Therefore, she is PTU from November of 2016 (equivalent to tenured professor). NMQ

CURRICULUM VITAE

Part A. PERSONAL INFORMATION

First and Family name Narcisa Martínez Quiles

Social Security, Passport, ID number

29039413G Age 53

Researcher codes

WoS Researcher ID (*) G-8514-2013

SCOPUS Author ID(*) 6602244874

Open Researcher and Contributor ID (ORCID) **

0000-0002-0366-6591

(*) At least one of these is mandatory (**) Mandatory

A.1. Current position

Name of University/Institution

Complutense University of Madrid

Department Immunology-Ophtalmology-ENT

Address and Country Facultad de Medicina, Spain

Phone number 913947431 E-mail [email protected] Current position Professor (PTU) From 2016-11-15

Key words Cytoskeleton, Actin, cell motility, EPEC, Wiskott-Aldrich Syndrome,

Autoinflammatory diseases (Innate Signaling-Cytoskeleton)

A.2. Education

PhD University Year

Doctor in Biology (Medical Immunology Program)

Complutense Univ. (Hospital “12 de Octubre”) 1997

Licenciado en Biologia (equivalent to Master’s level)

Autónoma University of Madrid 1982

A.3. JCR articles, h Index, thesis supervised… 4 Periods of 6 years of research officially recognized by CNEAI (sexenios, last 2015). Supervisor of 3 Ph.D. Thesis: 3 (1 co-directed), 2 with European Mention. Supervision of Students thesis: 3 graduation´s thesis, 5 master’s Thesis. Publications: 46% Q1; 26% D1. WOS Total citations: 948. Average citation 2012-16: 47. H index: 12. Outstanding publications: Predoctoral: J. Immunology (1st author); Post-doctoral: Nature Cell Biology (1st author), PI: Plos Pathogens (corresponding and last author); Cell Host and Microbe (collaboration). Part B. CV SUMMARY (max. 3500 characters, including spaces) Narcisa Martínez Quiles (NMQ) is a Professor (Titular) at the Complutense University. Graduated in Biology, specialty of Biochemistry and Molecular Biology by Autónoma University (1989). She ranked 4 / 628 in a national examination that allow her to join the National Biologist Residency Program (BIR) at the “12 de Octubre” Hospital, in the Immunology Division (1992-5). After its successful completion, she obtained the national certification by the Health Ministry as Immunologist Specialist that grants access to Hospitals. During this period, she participated in research and published several studies, including a Journal of Immunology as first author. She joined the Medical Immunology doctorate program at the UCM and obtained the doctoral degree in 1997. Although she was offered to continue in the division, at this point she decided to join the laboratory of Dr. Raif S. Geha, (Immunology Division, Children´s Hospital, Harvard Medical School) where she contributed to the study of the “Wiskott-Aldrich Syndrome”. She stayed there for 5 years as a postodoctoral fellow and two more years as an instructor/Research Associate (Dept. of Medicine, Harvard Medical School). This period shaped her scientifically and allow her to publish the research in top journals, such as Nature Cell Biology (first author). She received several awards, including the Paul A. Dobuler Prize for Excellence in Immunodeficiency Research. As a postdoctoral fellow, she was in charge of setting-up new cytoskeletal study techniques including cell microinjection. In 2004, she decided to return to Spain and applied to the very competitive public national program “Ramon y Cajal” where she ranked fifth in the Biomedicine area. In September of 2004 she joined the Dpt. of Microbiology, at the Pharmacy School, with the aim of refining its knowledge in host-pathogen interaction mechanisms in relation to the cytoskeleton. After the completion of this 5 year period, she obtained an I3 positive evaluation from the Ministry of Science that facilitated obtaining a contract as a Professor (Profesor Contratado Doctor) in September of 2009. In October of 2012 the researcher moves to the Dept. of Immunology, at the UCM Medical School. Although she obtained the certification as a civil servant professor (PTU) in 2011, due to the economic

CV date 2020-01-30

Page 2: CURRICULUM VITAE€¦ · crisis, is not until 2016 that she was able to apply for the position. Therefore, she is PTU from November of 2016 (equivalent to tenured professor). NMQ

2

crisis, is not until 2016 that she was able to apply for the position. Therefore, she is PTU from November of 2016 (equivalent to tenured professor). NMQ has established independent lines of research centered in the study of the regulation of the cytoskeleton during bacterial and cell motility. She has acquired international recognition in the field, as reflected by international collaborations. She has joint-in modest editorial board memberships and other groups in European Commission calls, including Infect-ERA, that will be follow up in the future. The group has stand-out with relevant publications in Plos Pathogens and Cell host and Microbe. Though the extreme difficulties endured in Science Funding in Spain during the last 5 years, she has managed to maintain collaborations and as a consequence of her persistence and hard-work, sustained a PI position. Currently she is a member of the Immunobiology Complutense Research group. Part C. RELEVANT MERITS

C.1. Publications (including books). Full publication list in PubMed.

1) Mohamed-Salem R, Rodríguez Fernández C, Nieto-Pelegrín E, Conde-Valentín B, Rumbero A, Martinez-

Quiles N. Hibiscus sabdariffa aqueous extract inhibits pedestals induced by enteropathogenic E. coli (EPEC)

formation. Plos One 2019. Mar 8;14(3):e0213580. doi: 10.1371/journal.pone.0213580.

2) Narcisa Martinez-Quiles and Raphaela Goldbach-Mansky. Updates on Autoinflammatory diseases Curr Opin

Immunol. 2018 Nov 16;55:97-105. doi: 10.1016/j.coi.2018.09.014. D1.

3) González-Jamett AM, Guerra MJ, Olivares MJ, Haro-Acuña V, Baéz-Matus X, Vásquez-Navarrete J,

2Momboisse F, Martinez-Quiles N, Cárdenas AM. The f-actin binding protein cortactin regulates the dynamics of

the exocytotic fusion pore through its SH3 domain”. Frontiers in Cellular Neuroscience (Front. Cell. Neurosci., 04

May 2017. IF (WOS 2016): 4.609. Rank (NeuroScience): Q1. Cited: 5.

4) Martinez-Quiles N, Feuerbacher LA, Benito-León M, and Hardwidge PR.“Contribution of Crk Adaptor Proteins

to Host Cell and Bacteria Interactions". Biomed Res Int. Article ID 372901, 13 pages, 2014. doi:

10.1155/2014/372901. IF (WOS 2014): 1.579. Rank (Biotechnology & Applied microbiology): Q3. Cited (WOS):1

5) Nieto-Pelegrín E, Kenny B and Martinez-Quiles N. Nck adaptors, besides promoting N-WASP mediated actin-

nucleation activity at pedestals, influence the cellular levels of enteropathogenic Escherichia coli Tir effector. Cell

Adh Migr. 2014;8(4):404-17. IF (WOS 2014): 4.505. Rank: (59/184 Cell Biology). Q2. Cited (WOS): 4.

6) Olivares MJ; Gonzalez-JamettAM; Guerra MJ; Baez-Matus X; Haro-Acuña V; Martínez-Quiles N; Cárdenas

AM.Src kinases regulate de novo actin polymerization during exocytosis in neuroendocrine chromaffin cells.

PLoS One. 2014 Jun 5;9(6):e99001. IF (WOS 2014): 3.24. Rank: Q1. Cited (WOS): 4

7) Elvira Nieto-Pelegrín Eugenia Meiler, José Manuel Martín-Villa, Maria Benito-León and Narcisa Martinez-

Quiles. Crk adaptors negatively regulate actin polymerization in pedestals formed by enteropathogenic

Escherichia coli (EPEC) by binding to Tir effector. PLoS Pathog. 2014 Mar 27;10(3):e1004022. IF (WOS 2013):

8.057. Rank: (10/116 Microbiology). D1. On the news: Redescubre UCM, Madrid i+d, SEI. Cited (WOS): 6.

Book chapters.

1) 2015. N. Martínez-Quiles. Chapter: SH proteins and cytoskeletal signaling. Edit. Springer. Heidelberg,

Germany. ISBN 978-3-319-20097-2.

2) 2011 Daniel Pérez-Nuñez and Narcisa Martínez Quiles. “Genetic factors that influence HIV infection: the role

of the major histocompatibility complex system”. InTech editorial (Croacia). ISBN 978-953-307-442-9.

3) 2010. E. Nieto-Pelegrín, E. Meiler, and N. Martínez-Quiles. “Cortactin, an oncoprotein targeted by pathogens

during infection”. ISBN (13): 978-84-614-6194-3.

Publications In collaboration with former Ph.D. advisor: 1. Arnaiz-Villena A, Enriquez-de-Salamanca M, Palacio-Grüber J, Campos C, CamachoA, Martin-Villa JM,

Martinez-Quiles N, Gomez-Casado E, Muñiz E. Characterisation and functional implications of the two new HLA-G alleles found in Amerindian and Caribbean populations. Hum Immunol. 2016 Jan 18. pii: S0198-8859(16)00007-0. doi:10.1016/j.humimm.2016.01.006. PMID: 26796363. http://www.sciencedirect.com/science/article/pii/S0198885916000070. 2016. IF (wok2016): 2.138. Ranking: 103/148 Q3 Immunology

2. Arnaiz-Villena A, Palacio-Grüber J, Muñiz E, Rey D, Recio MJ, Campos C, Martinez-Quiles N, Martin-Villa JM, Martinez-Laso J. HLA-DMB in Amerindians: Specific linkage of DMB*01:03:01/DRB1 alleles. Hum Immunol. 2016 May;77(5):389-94. doi: 10.1016/j.humimm.2016.02.011. Epub 2016 Mar 2. PubMed PMID: 26944519. 2016. IF. (WOK 2014): 2.138. Ranking 103/148 Q3 Immunology. Cyted by: 1

Page 3: CURRICULUM VITAE€¦ · crisis, is not until 2016 that she was able to apply for the position. Therefore, she is PTU from November of 2016 (equivalent to tenured professor). NMQ

3

3. Antonio Arnaiz-Villena, Ester Muñiz, Cristina Campos, Eduardo Gomez-Casado, Sandra Tomasi, Narcisa Martínez-Quiles, Manuel Martín-Villa, Jose Palacio-Gruber. Origin of Ancient Canary Islanders (Guanches): presence of Atlantic/Iberian HLA and Y chromosome genes and Ancient Iberian language. International Journal of Modern Anthropology Int. J. Mod. Anthrop. (2015) 8: 67 - 93 2015. http://www.ata.org.tn/fichier_PDF/IJMA-2015-issue8-OSA4-Origin-of-Ancient-Canary-Islanders.pdf. IF (ISI WEB of Knowledge 2015): No in WOK. www.ata.org.tn ; doi: http://dx.doi.org/10.4314/ijma.v1i8.4.http://www.laprovincia.es/gran-canaria/2016/01/25/aborigen-canario-bereber-o-iberico/784849.html

4. Recio, M.J; Muñiz, E; Palacio-Gruber, J; Martínez-Laso, J; Gómez-Casado, E; Martín-Villa, M; Martínez-Quiles, N; Campos, C; Arnaiz-Villena, A. Major Histocompatibility complex-DMB allelic diversity in old and new world nonhuman primates: Intraspecies pattern of evolution. International Journal of Modern Anthropology (2015) 8: 25 -47. 2015. Índice de Impacto (ISI WEB of Knowledge 2015): no in the wok. www.ata.org.tn; http://dx.doi.org/10.4314/ijma.v1i8.2 http://www.ata.org.tn/fichier_PDF/IJMA-2015-issue8-OSA2-MAJOR-HISTOCOMPATIBILITY-COMPLEX.pdf

5. Arnaiz-Villena, A; Muñiz, E; Campos, C; Gómez-Casado, E; Tomasi, S; Martínez-Quiles, N; Martín-Villa, M; Palacio-Gruber, J. Kurds HLA Genes: Its Implications in Transplantation and Pharmacogenomics Open Medicine Journal, 2015, 2, 43-47. http://benthamopen.com/ABSTRACT/MEDJ-2-43 2015.

C.2. Research projects and grants. Main Research Grant Projects as PI

1) A new actin polymerization inhibitory mechanism. Ref SAF 2017-82967-R. From 01/01/2018 to 12/31/2020. National Research Agency (MINECO). 108.900 € 2) A new immune cell migration inhibitory mechanism. Ref PR26/16‐20256 from 12/22/2016 to 12/21/2017. Santander Bank-UCM. 7.000 € 2) UCM validated Group # 970629. Grant aid. Ref: GR3/14 Santander Bank-UCM 11/21/2014-11/20/2015. 803,74 € 3) Study of the regulation and signaling of the oncogenic protein cortactin during bacterial and cel motility. Health Institute Carlos III. FIS PI09/00080, 01/01/2010-03/31/2014. 69.575 € 4) Study of the protein cortactin during bacterial motility. Médica Mutua Madrileña Foundation (#1754-2008): 07/23/2008-12/31/2010. 36.000 € (personel only) 5) Study of the protein cortactin during bacterial motility. Health Institute Carlos III. FIS. Ref: PI060004. 01/01/2006-12/31/2009. 113.740 € 6) Cortactin signalling and actin dynamics control in cell migration and bacterial invasion. Marie Curie International Reintegration Grant, European Comission FP6-2004-Mobility-12. 01/01/2006-12/31/2007. 80.000 €. Postoctoral Fellow participation in Grants PI: Raif S. Geha - Signaling and Cytoskeleal Organization in Blood Cells. NIH/2P01HL059561 - Role of SLP-76 in thymic development and FCR function. NIH/5P01AI35714 - Role of CD40-TRAF interaction in B cell activation and inmmunoglobuling class switching- - March of Dimes and SLP-76 Immunodeficiency. Baxter Pharmaceuticals. Predoctoral Fellow participation in Grants PI: Antonio Arnaiz Villena - Project FIS 94-0367. “Comparative Study of the DNA sequences of HLA transporter genes (TAP1 y TAP2) and HLA-G in Type I Diabetes Mellitus and Control Spanish Populations. - Ramón Areces Foundation 1995. PI: Antonio Arnaiz Villena. HLA and HIV association. - FIS 96-5569. “Comparative Study of the DNA sequences of HLA-G gene in Hemochromatosis and Control Spanish Populations; Effect of HLA-G Compatibility in Bone Marrow Transplantation. C.3. Contracts

Predoctoral contract for i+d+i young professionals Madrid Community/European Social Fund. Ref. CT101/18-CT102/18/PEJD-2018-PRE/BMD-8403. PI NMQ. 2019, 1 year.

Postdoctoral contract for i+d+i young professionals Madrid Community/European Social Fund. Ref. CT4/17/CT5/17/PEJD-2016/BMD-2475. Fellow: Marcos Díaz Muñoz. PI NMQ. 04/07/2017, 1 year.

Predoctoral Fellowship (FPU) Ministry of Eduaction. AP2009-1529. Fellw: Eugenia Meiler Rodríguez. PI NMQ.11/01/2010 - 01/14/2014.

Predoctoral Fellowship (FPI) Ministry of Innovation (BES-2008-009174). Fellow: Reda Mohamed Salem. PI NMQ. 03/25/2011 - 05/26/2013.

Page 4: CURRICULUM VITAE€¦ · crisis, is not until 2016 that she was able to apply for the position. Therefore, she is PTU from November of 2016 (equivalent to tenured professor). NMQ

4

Madrid Community official Internship for community college students (ref 78 UCM- Valle del Miro) Felow: Lisseth Pelaez Estrada. PI NMQ.01/17/2013-06/06/2013 (710 Hours).

UCM Predoctoral Fellowship. Fellow: Elvira Nieto Pelegrín. PI NMQ. 01/01/2009,- 12/30/2012.

C.4. Patents C.5. Scientific Management: director of a Complutense validated Research Group (07-09-2012 to 2017). Member of the Medical School Research Committee (2013-7). C.6. Editorial Board Member: Plos One (2019-)“Case Reports Immunology” (2011-7); OA Immunology (2013-) C.7. Awards. - 2018 Fulbright/Ministry of Education Visiting Resarcher at the NIH (Ref. PRX17/00272). - 2012 Selected (41 selected out of around 14.500 participants) to the final Marie Curie FP6 WP meeting (European Comission). Publication “From Face to Face”. Portraits of Marie Curie Fellows ISBN 978-92-79-23909-0. July 3-4 2012. Bruxels. - 2002. Von L Meyer Fellowship Award. Children’s Hospital. Boston, MA. - 1999 Paul A. Dobuler Prize for Excellence in Immunodeficiency Research. Boston. MA. - - - 1998 New Investigator Award CIS (Clinical Immunology Society) C.8. Research Visits. 2018 (6 months) National Institutes of Health (NIAID). Autoinflammatory Translational Unit. Raphaela Goldbach-Mansky Lab. (1997-2002) Post-doctoral Fellow and 2002-4 “Instructor/Research associate”. Raif S. Geha Lab. Children´s Hospital. Harvard Medical School. C.9. 2008 Science Ministry positive I3 evaluation as oustanding researcher. C.10. 2011. Officially recognized level as “Profesor Titular de Universidad” (April 7, 2011) C.11. 2003 Ranked Fith in “Ramón y Cajal” program (Biomedicine). Ministry of Education. C.12. 1992 Ranked fourth out of 628 candidates for Biology Intership. Health Ministry. C.13. Reviewer for BMC Cell Biology, Current HIV Research, Cell Communication and Signaling, PloS One; Nature Scientific Reports, Cell Adhesion and Migration etc. C.14. Congress attendance: 43 international (5 short-talk) and 20 national communications C.15. Memberships:1993 Immunology Spanish Society Member. 2013 Member of the Marie Curie Fellow Association. 2014 Member of the Lacer Coalition (Latin American Coalition for Escherichia coli Research. Coordinator: Alfredo Torres at Sealy Center for Vaccine Development UTMB Health. Texas (USA). 2016 Member of the “Madrid Immunology Society” (SICAM). 2018 Fulbright Association.

Page 5: CURRICULUM VITAE€¦ · crisis, is not until 2016 that she was able to apply for the position. Therefore, she is PTU from November of 2016 (equivalent to tenured professor). NMQ

5

Teaching Activities First experience teaching was as Tutor in the “Course in Immunology, Microbiology and Infection Diseases

(IMID)”. Department of Pediatrics, Harvard Medical School (Harvard University). Boston (USA). April-June

2004 (30 credits). Coordinator: Prof. Arlene Sharpe. Invitation to participate in the 2005-6 course.

Currently I have fulfilled 2 Periods of 5 years of teaching officially recognized by the UCM (Quinquenios, last

2015).

Teaching Training Courses Received

Course on teaching innovation. Cum Laude School. Madrid. 26 Sept 2015.

Official Cambridge Proficiency in English Certificate (2016) (C2 European level). CSIM-UCM. (75 hours).

Communications Strategies for English-Medium Instructions in the International University. Intercom Course UCM (20 horas). CSIM-UCM. 20-24 June 2016.

“Flipped learning in higher Education”. UCM. September 2017 (20 h).

Teaching activity Course Academic Year

1 IMDM (Harvard University) 2003-4

2 Prácticas de MICROBIOLOGÍA GENERAL (100053-219, 3er curso Licenciatura Farmacia)

2005-2006 to 2011-12

3 Prácticas de FUNDAMENTOS Y TÉCNICAS INMUNOLÓGICAS (FYTI) (100050, 2º curso de la Licenciatura de farmacia)

2007-8 to 2010-11

Teoría de FUNDAMENTOS Y TÉCNICAS INMUNOLÓGICAS (100050, 2º curso de la Licenciatura de farmacia).

2009-10 and 2010-11

4 Prácticas de INMUNOLOGÍA (803513; 2º Curso del Grado en Farmacia). 2011-12

Teoría de la asignatura INMUNOLOGÍA (803513, 2º curso del Grado de Farmacia). 2011-12

Doctorado en Microbiología y Parasitología

5 BASES MOLECULARES DE LA PATOGÉNESIS MICROBIANA 2006-7, 2007-8, 2008-9

6 FUNDAMENTOS DE INVESTIGACIÓN EN MICROBIOLOGÍA 2009-10

Master de Microbiología y Parasitología: Investigación y Desarrollo

7 DISEÑO EXPERIMENTAL Y METODOLOGÍA DE LA INVESTIGACIÓN (603660) 2010-11

8 SEMINARIOS EN INVESTIGACIÓN (603673) 2010-11

9 BASES MOLECULARES DE LA PATOGENIA Y TERAPIA ANTIMICROBIANA Y ANTIPARASITARIA (603666)

2010-11 to 2011-12

10 SEÑALIZACIÓN CELULAR (603670) 2010-11 to 2011-12

11 Tutorización de alumnos TFM

Doctorado en Inmunología Médica (mención de calidad por la ANECA (ref mcd-2003 00886)

12 INMUNODEFICIENCIAS CONGÉNITAS 2006-7 to 2008-9

13 TEMAS DE INVESTIGACIÓN EN INMUNOLOGÍA (700561) 2006-7

Máster Universitario en Virología. Facultad de Veterinaria

14 MÉTODOS DE ESTUDIO DE LOS VIRUS (A3) (600003). 2010-11 and 2011-12

Máster Interuniversitario de Investigación en Inmunología

15 INMUNOLOGÍA MOLECULAR (603253) 2010-11 to 2012-13

16 INTERACCIÓN PATÓGENOS SISTEMA INMUNE (603256). 2011-12

17 Prácticas de INMUNOLOGÍA (100076, 5º Curso de la Licenciatura de Farmacia) (). 2011-12, 2012-13, 2013-14

18 Prácticas de INMUNOLOGÍA (1er curso del Grado de Medicina). 2011-12 to present

SEMINARIOS DE INMUNOLOGÍA (1er curso del Grado de Medicina). 2011-12 to present

19 SESIONES BÁSICO-CLÍNICAS (Asignatura Práctica Clínica III) 2012-13, to present

20 Teoría INMUNOLOGÍA APLICADA (803482, Asignatura de 6 créditos ECTS). Grado de Bioquímica.

2012-13 to present

Máster Universitario en Investigación en Inmunología UCM

21 INTERACCIÓN PATÓGENO/INMUNIDAD (607653) 2013-14 and 2014-15

22 INMUNOLOGÍA MOLECULAR (607650) 2013-14

23 INMUNOLOGÍA HUMANA Y CLÍNICA (607654) 2014-15, 2015-16

24 Trabajo Fin de Master. Tutoría de alumnos 2012-13 to present

Doctorado Investigación Biomédica. R.D. 99/2011 Código 5600682

25 Tutorías de alumnos 2014-15 to present

26 Inmunoterapia del cáncer e Inmunopatías (Grado Medicina). Cod 805028. 2016-17

27 Máster Universitario en Investigación en Medicina Traslacional (065t) Investigación Traslacional en Enfermedades Inflamatorias y Crónicas (Cod. 608770)

2017-18 to present

28 Máster Universitario en Investigación en Medicina Traslacional (065t) Bases Fisiopatológicas y Terapéuticas de enfermedades Inflamatorias y Crónicas (Cod. 608775)

2017-18 to present

Page 6: CURRICULUM VITAE€¦ · crisis, is not until 2016 that she was able to apply for the position. Therefore, she is PTU from November of 2016 (equivalent to tenured professor). NMQ

6

Other teaching

2019. Course “New concepts in advanced Immunology and Immunnotherapy” (Nuevos avances en

inmunología e inmunoterapia”) to community college teachers (profesores de secundaria de la comunidad de

Madrid), Organized by the “centro territorial de innovación y formación madrid-capital”. February 5-26. (5

hours).

2018. Practical course on Immunodiagnostic training (técnicas de inmunodiagnóstico”). Community College

in Health system (Formación profesiónal en sanidad). April 28-29. 15 Hours. Lanzarote (IES ZONZAMAS)

35000321.

Participation in Teaching innovation projects

INMUNOMEDIA 7.0. Immunomedia project: learning, lecturing and spreading Immunology Coordinator Prof.

Alfredo Corell Almuzara. Universidad de Valladolid. Since 2015-16. Funding: FECYT FCT-16-11509. 8.000 €

Participants: Universidad de Valladolid, Universidad Complutense de Madrid, Universidad Europea de

Madrid, Universidad de Alicante, Universidad Politécnica de Valencia, Universidad de Coimbra y Université

Paul Sabatier (Toulouse III-Francia). Publication: Immunomedia project: learning, lecturing and spreading

Immunology. Autores: A Corell, C Martin Alonso, JC Zarzuela, LA Sanz, JC Aragon, JM Sempere, D

Hudrisier, P Rodrigues Santos, S Alvarez Alvarez, V Arnaiz, MJ Verdu Perez, LM Regueras Santos, JP de

Castro Fernandez, N Martinez-Quiles, Reche Gallardo, AS Pascual Garcia, P Martinez Peinado, JR

Regueiro. 2016/8/1. EUROPEAN JOURNAL OF IMMUNOLOGY Volumen 46, Páginas 1167-1167.

Recognized by the “Fundación Lilly” “XI MEDES Prize 2018” as the best Project promoting the use of

Spanish language in supporting spreading of biomedical knowledge”

https://www.fundacionlilly.com/es/actividades/medes-medicina-en-espaniol/resumen-convocatoria-premios-

medes-2018.aspx

Participant in the Teaching Innovation Project (“Proyecto innovación docente”) UCM 2017-18

Títle: “Competición de pósters científico/divulgativos como experiencia de inmersión al

aprendizaje activo e integral por parte del alumnado de Ciencias de la Salud”. Ref: 252. Coordinator: María

Paloma Sánchez-Mateos Rubio.

Positive evaluations “Docentia Program ” (UCM)

o 2011-12. Inmunología (Grado de Farmacia, Facultad de Farmacia, UCM).

o 2013-14. Inmunología Aplicada (Grado de Bioquímica, Facultad de Químicas, UCM).

o 2014-15. Inmunología Aplicada (Grado de Bioquímica, Facultad de Químicas, UCM).

o 2016-19 Inmunología Aplicada (Grado de Bioquímica, Facultad de Químicas, UCM). Inmunología

Humana y Clínica (Master Inmunología). Very Positive.